Clinical trial
Study of the Blood-Interstitial Glucose Gap and Its Prediction of Metabolism and Prognosis in Critically Ill Patients
NCT07251764 is registered in ClinicalTrials.gov with Chinese Medical Association as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Blood-Interstitial Glucose Gap and Its Prediction of Metabolism and Prognosis in Critically Ill Patients
- Lead sponsor
- Chinese Medical Association
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 13, 2023
- Completion date
- October 1, 2025
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, metabolism disorders